2015•Gynecologic OncologyOpen access

Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer

Helen E. Dinkelspiel, Ana I. Tergas, Lilli A. Zimmerman, William M. Burke, June Y. Hou, Ling Chen, Grace Clarke Hillyer, Alfred I. Neugut, Dawn L. Hershman, Jason D. Wright

Open full text 21 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 21 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Chemotherapy, Stage (stratigraphy), Internal medicine, Ovarian cancer, Proportional hazards model, Oncology, Cancer

Back to paper search Browse research topics Original source

Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer — Research Paper | ScholarLens